Swine-vaccine developer recognized as Top Company at this year’s Partnering for Growth Biotech Innovation Showcase & Forum 

CHAMPAIGN, Illinois (March 24, 2017) – Aptimmune Biologics was awarded this year’s Biotech Innovation Showcase’s Top Company Award at the 2017 Partnering for Growth Biotech Innovation Showcase & Forum that took place this week in Ankeny, Iowa.

At the Showcase, 12 emerging companies in four categories (agricultural technology, animal health, human health and bio materials) made formal presentations to a panel of eight business leaders from the fields of agricultural biotechnology, intellectual property, human health and small business development. Steve Berger, Aptimmune Biologic’s development director, made the award-winning presentation to the judges.

“We are pleased Aptimmune has been recognized as a bioscience leader by the Iowa Biotechnology Association. This award will only continue to inspire our employees to reach new levels of innovation in the animal health industry,” said Aaron Gilbertie, CEO of Aptimmune Biologics. “Being chosen as Top Company from this group of outstanding innovators says a great deal about the quality of work being done by Aptimmune. The Showcase was an excellent opportunity for our employees to network with other innovators and industry leaders and to highlight some of Aptimmune’s best and brightest ideas.”

The Iowa Biotech Association’s Partnering for Growth Showcase features an investor conference and industry forum that joins innovators, investors and biotech leaders together over the course of a day and a half. It is a premier event for learning, investing and networking with various sectors of the biotech industry.  Start-up presentations focused around the development of biofuels and biomaterials; advances in food, ag and plant genetics; progress in animal health; as well as human health and medical technology. The Innovation Showcase winner received a $5,000 cash prize from the Association.

Aptimmune Biologics, based in Champaign, Ill., specializes in developing and marketing a portfolio of revolutionary mucosal vaccines that provide answers for the most costly viral diseases impacting the swine industry. Aptimmune’s first vaccines are focused on addressing two major viral respiratory pathogens, Porcine Reproductive and Respiratory Virus (PRRSV) and influenza. To learn more, visit aptimmune.com. 

###

CONTACT:

Aaron Gilbertie
60 Hazelwood Dr
Champaign, IL 61820
317-690-7097
agilbertie@aptimmune.com